His most recent case was five-year-old bulldog called Jesse.
Guillaume said: "Jesse was suffering from both atlantoaxial instability and a spinal arachnoid diverticulum in the thoracic spine.
“As a result of the two conditions, he had lost a lot of mobility and was dragging his hind legs behind him.
“We decided it was best to carry out two separate operations, prioritising the surgery to tackle the atlantoaxial instability as that was potentially life-threatening.
“I used a new technique for this, adopting a dorsal approach, which involves an insertion through the top of the neck when normally this type of surgery is generally performed ventrally, through the bottom of the neck.
“We have had great success with this approach so far.
"The normal mortality rate is between 5 to 10%, however, we have now done 20 of these procedures together with colleagues, all of which have been successful.
“The main advantage of the technique is it likely reduces the risk of complications, which is why I prefer it.
“With the ventral approach you go through the soft tissue and nerves in the neck which brings the risk of vomiting, regurgitation, megaesophagus, swelling and even tracheal injury.” =
Guillaume has co-authored a publication on the dorsal surgical technique which can be found at: https://doi.org/10.3390/life11101039
Hospital director David Walker said: “Ewan Ferguson has been providing our dermatology service for many years and with Hilary joining him, we will now be able to provide a full-time service to support our referring vets, their clients and pets.
He added: “We are really delighted that Hilary is joining the dermatology team at Anderson Moores. Her passion for dermatology is infectious and with a particular interest in chronic ear disease, I’m sure she’s going to be very busy!”
Hilary has been a past Board member and organiser of the scientific meetings for the British Veterinary Dermatology Study Group, a member of the In Practice editorial board for 20 years and a past chief examiner for the RCVS Small Animal Medicine Certificate. She continues to act as a mentor for the BSAVA PGCertSAM course and as an assessor for the RCVS Advanced Practitioner in Small Animal Dermatology.
Hilary has worked in first opinion and referral clinics around the south west, including running her own dermatology referral service within several veterinary practices. From 2018 to 2021, she had been working as lead clinician in dermatology at Langford Vets (University of Bristol).
Hilary said: “I’m very excited to be joining the fantastic team at Anderson Moores and really looking forward to helping make a difference with the new dermatology service we’ll be offering.
For more information, visit www.andersonmoores.com.
The College is the first UK centre to offer the course, and says it provides a new route for career progression for RVNs working in clinical practice who are looking to expand their clinical skills and knowledge.
Clare Renwick, Lecturer in Veterinary Nursing at Askham Bryan College said: "The Veterinary Nursing team at Askham Bryan College has developed an industry-relevant programme of study that fits in with both the personal and professional lives of learners.
"Taught primarily online over one year, students will be provided with all the tools and resources required to develop their knowledge through evidence-based nursing, industry-expert guest lecturers and professional discussions. In-person practical sessions will allow the RVN to extend and demonstrate their practical expertise ready for assessment.
"We are very excited to roll out this course which we feel will fill enhance our current offering in the subject area.”
The course involves completion of modules that extend skills and knowledge when leading consultations and clinics.
It is a regulated level 5 qualification and offers Suitably Qualified Person (SQP) registration following successful completion of assessments allowing the RVN in practice to further extend their nursing clinic offerings to pets and their owners.
Applications are now being accepted for a February 2021 intake.
For more information, visit http://www.askham-bryan.ac.uk/ or contact: tracey.seymour@askham-bryan.ac.uk or clare.renwick@askham-bryan.ac.uk.
The findings will be published in a freely-available and independently-authored report.
Jane Balmain, Chief Operating Officer at Vets4Pets (pictured right), said: “The last 18 months have been indescribably tough for everyone, not least the veterinary practice teams. Soaring levels of pet ownership coupled with recruitment challenges have meant that an already-stretched profession has been almost brought to its knees.
"As a profession, you’ve always put pets first. But now it’s time to also concentrate on you - the vets, nurses and support teams that make up our beloved sector. We want to hear how you’re feeling and give you the power to help us make change.
“By launching this sector-wide survey, we’re kick-starting a vital conversation to protect the wellbeing of vet teams and the future of the profession. We believe that, by sharing experiences openly and honestly from all corners of the sector, we can come together to bring about the much-needed changes to ensure it remains an attractive, long-term career option.”
The survey, which runs until 16th November 2021, can be completed at www.projectlisten.co.uk. Respondents will remain anonymous and no data will be collected via the survey.
Rominervin contains 10 mg/ml romifidine hydrochloride, equivalent to 8.76 mg romifidine, presented in a 20 ml vial.
It can be used as a sedative to facilitate handling, examination, minor surgical interventions and minor procedures or as a premedication prior to administration of injectable or inhalation anaesthetics.
Rominervin can also be used in combination with synthetic opiates such as butorphanol to provide deeper sedation or analgesia.
Dechra Brand Manager Emma Jennings said: "Rominervin is highly effective as it has a longer duration of action than other alpha-2 agonists1. It starts to work within one to two minutes with maximum sedation achieved between five and 10 minutes.
"It is yet another valuable addition in our equine anaesthesia and analgesia range that has been designed to provide vets with the therapies they need to operate successfully in day-to-day practice."
Rominervin can be used in conjunction with Dechra’s equine anaesthesia and analgesia app, designed to help veterinary professionals choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates.
For more information visit: www.dechra.co.uk/products/equine
It might explain why, according to the research, around 14% of British adults actively encourage fox visitors into their garden, with 10% of adults leaving out food, water or toys for foxes and 48% of them admitting they would feel disappointed if their garden fox did not return at night.
Bayer highlights research which showed an increase in the number of foxes infected with Angiostrongylus, from 7.3% in 2008 to 18.3% in 20152,3.
More recent work led by the aptly named Professor Mark Fox at the Royal Veterinary College has shown that, in the Greater London area, nearly three out of four foxes (74.4%) are infected with the parasite.4
Mark said: "We had previously mapped the distribution of Angiostrongylus in pet dogs by seeing how many cases every small animal practice in Britain had seen over the previous 12 months. This revealed the parasite’s widespread distribution coupled with hotspots of infection in Greater London/south-east England and South Wales, where dogs were four to five times more likely to be infected than elsewhere in the country.
"We then investigated why hot spots were seen in these locations and, apart from land type, dog density and climatic factors, we found that the mere presence of foxes locally increased the risk of infection in dogs five-fold."
"The overall prevalence of infection in Greater London was very high, at just under 75 per cent4, and prevalence was maintained at this level throughout the year. These results suggest that foxes act as year-round, wild animal reservoirs of infection for urban dogs."
Donna Tomlinson, Bayer Senior Brand Manager said: "The recent ‘pet foxes’ pet owner research results coupled with the lungworm prevalence fox studies highlights the growing concern of the spread of Angiostrongylus vasorum in the UK and the need for adequate preventative measures for pet dogs.
"Veterinary professionals are perfectly placed to advise dog owners on the risk of their pets becoming infected with the parasite, including the growing role of foxes as potential wild animal reservoirs of Angiostrongylus, as well as advising pet owners to use a monthly spot-on prevention such as Advocate.
"Treatment with products containing moxidectin, such as Advocate, not only kills lungworms present at the time of treatment but also kills larvae after ingestion preventing new infections. Regular monthly use prevents disease and ensures that no lungworm larvae are shed in dogs’ faeces which helps to prevent the spread of the parasite in the environment."
To highlight the increased prevalence of lungworm in foxes Bayer has created a poster for veterinary practices, which you can get from the Bayer Vet Centre at: https://www.vetcentre.bayer.co.uk/marketing-and-resources/advocate-fox-poster
References
Professor Susan Dawson (pictured right), Chair of the Mind Matters Taskforce, will introduce the event and will be followed by the symposium’s plenary speaker, Rory O’Connor, Professor of Health Psychology at the University of Glasgow and President of the International Association for Suicide Prevention.
Rory's talk: ‘When It is Darkest: Understanding Suicide Risk’ will draw upon his research and work on the psychological processes which precipitate suicidal behaviour and self-harm, an area of expertise that has seen him advise the Scottish Government, as well as other national and international organisations, on suicide prevention strategies.
The next presentation will be from Dr Victoria Crossley from the Royal Veterinary College and Navaratnam Partheeban, co-founder of the British Veterinary Ethnicity & Diversity Society (BVEDS), on their research into the mental health impact of racism and discrimination on Black, Asian and minority ethnic (BAME) veterinary surgeons.
They'll be followed by Professor Neil Greenberg and Dr Victoria Williamson from King’s College London, who will talk about their research into the impact of ‘moral injury’ on the mental health and wellbeing of vets.
The day will then split into different research streams with presentations on a variety of topics including: the impact of cyberbullying and harassment; the wellbeing of veterinary interns and residents; stigma and stress in veterinary nursing; mental health awareness training in the undergraduate veterinary curriculum; and the relationship between ‘patient safety culture’ and staff burnout.
Lisa Quigley, Mind Matters Manager, said: “As with previous years the Mind Matters Mental Health Research Symposium promises to be a very informative and important day in terms of international researchers coming together to share their research, their conclusions, areas for further work and study, and best practice.
"Some of the topics we will be discussing, such as suicide, will be difficult, but research into issues affecting the international veterinary community is a vital first step to putting in place strategies and support mechanisms to help those in need. This is why research will be one of the key strategic priorities for the Mind Matters Initiative and our forthcoming actions in this area will be published later this year in our Mind Matters Initiative Strategic Plan.
“I would like to thank Dr Rosie Allister, a veterinary mental health researcher from the University of Edinburgh and manager of Vetlife Helpline, for putting together an excellent programme.
"As with previous years we are also offering free attendance of the symposium to those who have lived experience of mental ill-health, those who are currently not working, and veterinary and veterinary nursing students. If you have any queries about the event, please don’t hesitate to contact me on l.quigley@rcvs.org.uk to discuss further.”
Registration for those not entitled to a free ticket is £10.
To register for the event visit: www.vetmindmatters.org/events.
Specifically, remote assessments will make sure that practices are continuing to meet Veterinary Medicines Regulations, the Core Standards of the PSS and other key standards relating to the practice's accreditation type and level.
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, said: “We have introduced these remote assessments as a means of being able to quality assure veterinary practices that are either in the Scheme or who wish to join it, while still making sure that public health is safeguarded and that the burden our face-to-face assessments may place on practices is reduced.
"All our Practice Standards Scheme Assessors will be trained in carrying out remote assessments, and practices that are due an assessment will be given the full details of how it will work in advance, just like if a physical assessment of the premises were taking place.
"In the immediate-term we will be prioritising those practices that were due assessment visits in March, April and May this year which were cancelled due to the nationwide lockdown and they are currently being contacted to make arrangements. We will then start a rolling programme of visits for the other delayed assessments over the next few months. We will aim to give all practices at least one month’s notice before a visit takes place."
In order to help veterinary teams at RCVS-accredited practices understand the changes and its implications, the RCVS has produced a list of anticipated FAQs containing the details of how remote assessments will work. These can be found at: www.rcvs.org.uk/setting-standards/practice-standards-scheme/remote-assessments.
Those with any additional enquiries should contact the RCVS Practice Standards Team on: pss@rcvs.org.uk.
The Committee had found Dr Elefterescu guilty of serious professional misconduct in relation to a number of charges which covered issues such as dishonesty, poor record-keeping, and failure to carry out adequate clinical examinations.
The full charges and findings of the RCVS Disciplinary Committee can be found at: www.rcvs.org.uk/disciplinary.
The Judicial Committee of the Privy Council held the appeal hearing in October last year with three Justices of the Supreme Court - Lord Kerr, Lord Carnwath and Lord Kitchin – comprising the Board.
The basis of the appeal to the Privy Council was that the Committee’s findings on the facts of the case were flawed, with his counsel saying that Dr Elefterescu 'strenuously disputes the findings by the Committee of his dishonesty and lack of professional competence and submits that there is no adequate basis for them in the evidence’.
His counsel also told the Board that the Disciplinary Committee’s sanction failed to take into account mitigating factors and that the decision to remove Dr Elefterescu from the Register was disproportionate.
In relation to the appeal against the Disciplinary Committee’s findings on the facts, the Board was not persuaded by any of the arguments put forward on behalf of Dr Elefterescu. These arguments included that the RCVS had failed to call relevant witnesses and had failed to make Dr Elefterescu aware of the significance of some evidential matters, disclosed to him.
In respect of the sanction, the Board was also unpersuaded by the arguments put forward by Dr Elefterescu’s counsel, namely that it was too harsh in its assessment of aggravating factors, did not give adequate weight to mitigating factors, and that it failed to distinguish lack of competence from misconduct.
In its judgment on the arguments put forward by Dr Elefterescu’s counsel, the Board said: "It is the opinion of the Board that these criticisms are not well founded. The Committee considered with care Dr Elefterescu’s proven and admitted conduct in relation to each of the charges and whether it fell below or far below the standard to be expected. It is to be noted in this regard that a number of the charges which were either admitted or upheld were not the subject of any challenge on this appeal.
"Overall, the Committee found that Dr Elefterescu’s clinical failures were very serious, involved failures in the basics of animal care, resulted in animal suffering and involved widespread breaches of the respondent’s [RCVS] code of professional conduct. It also expressed particular concern about its findings of dishonesty, and rightly so. That conduct was, in its view, ‘at the top end’ of disgraceful conduct in a professional respect. What is more, Dr Elefterescu had a lack of insight into his failings and a wholly unjustified confidence in his abilities which constituted an ongoing risk to animal welfare."
"These were findings which the Committee was clearly entitled to make and, in the light of them, the Board is firmly of the view that the decision of the Committee to direct the removal of Dr Elefterescu’s name from the Register cannot be impeached. The Board rejects the criticisms made of the Committee’s reasoning and the conclusions to which it came. The direction that Dr Elefterescu’s name must be removed from the Register was appropriate and proportionate."
The Judicial Committee’s full findings can be found at www.jcpc.uk/cases/docs/jcpc-2018-0060-judgment.pdf.
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
To use the service, you order recycling boxes to suite your needs, and then place them where it will be most convenient for staff to throw the rubbish in.
Once full, you send the box back to TerraCycle via UPS.
It is then saved from incineration or landfills and recycled by TerraCycle.
Once collected, products and packaging are sorted and separated by material composition.
The separated items are then cleaned, shredded, and made into new recycled products such as outdoor furniture and decking, playgrounds, benches, or watering cans.
Hannah James, Head of Environment, Social & Governance at VetPartners said: “We started using the Zero Waste Boxes at our practices during the pandemic to recycle the large volumes of PPE being used, and they were instantly popular with practice teams.
"We’re now recycling plastic packaging, pet food packaging and medicine blister packs through TerraCycle as well, and since 2020 we’ve saved over 14 tonnes of waste from landfill and incineration.
"The Zero Waste Boxes are an important feature of our sustainability strategy, providing a solution for much of the waste generated by veterinary practice that isn’t hazardous and yet isn’t widely accepted for recycling.”
www.vetcycle.co.uk
Zesti comprises three ranges:
The Spirit range is a more standard looking scrub, manufactured from Alsi-Flex. The ‘Mode’ range looks a little more figure hugging, with an exclusive colour palette, and the Power range has a more sporting look.
Greg Houlston, General Manager, said: “Our healthcare workers need clothing that is practical and comfortable above anything else, yet our market research showed us that when it comes to scrubs with stretch, choice is limited in the UK compared with other markets such as the US.
“Veterinarians in particular need workwear that is especially hard wearing as the nature of their work means their clothing can be especially susceptible to rips, tears and soiling.
“We set out to create a brand that answered the need for more flexibility while challenging the perception that workwear should be dull and boring, and Zesti was born – a vibrant and contemporary range of garments, sustainably designed, to inspire confidence and positivity.”
Sara Catanzaro, Design Manager, added: “Our tailored garments offer exceptional attention to detail while being strong, hard wearing and resilient.
"They can be laundered domestically or industrially up to 60 degrees which is ideal for infection control.
"We’re already witnessing considerable demand as we believe we’ve hit the perfect balance between function and fashion.”
For more information, visit www.zesti.co.uk
The College is currently collaborating with VetLed, a leading provider of Human Factors skills training for veterinary professionals and the British Veterinary Nursing Association (BVNA), to launch the “VetLed Safe to Speak Up campaign” on the 2nd May.
The campaign aims to empower all members of the veterinary team to talk openly about their mistakes, concerns and new ideas by raising awareness of the importance of psychological safety.
The College says psychological safety is the belief that there won’t be negative repercussions as a result of vocalising thoughts, ideas or concerns, and is a beneficial value for practices to adopt.
Safe to Speak Up will include a social media campaign that raises awareness of the benefits of psychological safety and provides advice for how workplaces and individuals can apply psychological safety in their practice.
The Safe to Speak Up campaign will also feature a day of interactive workshops focussed on psychological safety on the 11th May.
The day will include free-to-attend sessions from VetLed that will explain what psychological safety is and how it can be created and maintained in practice.
Later, there will be four Veterinary Nurse Think Tanks, 90-minute interactive learning and discussion sessions that cover key Human Factor themes:
Lisa Quigley, Mind Matters Initiative Manager, said: “Every single vet nurse should feel comfortable and psychologically supported in their role, and we hope that the training and awareness campaigns that we are running over the upcoming year will ensure that more VNs will feel empowered to talk about their mental health and wellbeing at work.”
Alex Taylor, BVNA President, said: “The BVNA are so pleased to be part of the Civility Training, Think Tanks, and Safe to Speak Up Campaign, especially as these fall in line with our current theme of 'building resilience'.
"We recognise how important the mental health of veterinary nurses is, not just for their own wellbeing, but for the good of the workforce too.”
For more information about the MMI training sessions or to book a place on our Civility Training https://www.vetmindmatters.org/training/
In the study1, records from a large commercial diagnostic laboratory were searched for canine skin masses submitted for histopathology from dogs aged between 0-12 months from practices based in the UK and Europe.
For each case, data on the breed, age and sex of the dog, the body location of the sample, and the diagnosis made by the original reporting histopathologist were recorded.
For the purposes of the study, masses were included which were cystic, hyperplastic or neoplastic, but not inflammatory.
Submissions of samples from the eyes, anal glands and nails were excluded and only MCTs submissions that were cutaneous were included.
Risk factor analysis using multivariable binary logistic regression modelling was carried out for skin masses with at least 30 submissions.
Professor Ken Smith, corresponding author for the paper, said: “A total of 2553 submissions for a skin mass were included in the study.
"Across all the skin masses, the majority (94.3%) were neoplastic in nature.
"Of the neoplastic lesions, 98.5% were considered benign.
"Almost all of the benign neoplastic lesions were of round cell origin (94.0%), whereas most of the non-neoplastic lesions were derived from the epithelium (93.8%).
“The most common histopathological diagnoses for skin masses were histiocytoma (86.6%), papilloma (3.5%), dermoid cyst (3.3%), follicular cyst (1.7%) and MCT (1.4%).
"Multivariable analysis revealed that Labrador retrievers, Boxers and Golden retrievers had reduced odds of histiocytoma compared to crossbreed dogs.
"Male neutered dogs had lower odds of dermoid cyst compared with female entire animals.
"Dogs aged 9 to 12 months had significantly higher odds of follicular cyst compared with dogs aged under 6 months, whilst dogs aged over 6 months showed significantly higher odds of MCT than dogs under 6 months of age.”
Nicola Di Girolamo, Editor of JSAP, said: “Retrospective studies that include a large number of cases such as this one are an invaluable resource for clinicians working in any setting.
"The findings of this study corroborate those of previous research, suggesting that a skin mass in a young dog is very likely to be a histiocytoma.
"However, the risk factor analysis in this paper identified a number of different predilections to those previously recognised, indicating a need for continued research in this area.”
The full article can be found in the January issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13418
Reference
Prior to becoming COO, Tim was Managing Director of three referral hospitals owned by Linnaeus – Davies Veterinary Specialists, London Veterinary Specialists and Southfields Veterinary Specialists – and a number of its primary care sites.
Prior to joining Linnaeus, Tim worked in Iceland, where he was a vet for the Icelandic Government.
On his return from Iceland in 2016, he joined Village Vet and then progressed into a range of regional management and practice leadership positions across the industry.
Tim said: "I am proud to be part of our wonderful, unique industry that, although currently facing a number of challenges, continues to make such a difference to the lives of our patients and their owners every day.
“In my first vet role in mixed practice, I was fortunate to receive brilliant support, guidance and encouragement from my team.
"Since then, I have always wanted to do the same for my colleagues, particularly those who are just starting their careers.
“I have used my experience within the veterinary profession to support some fantastic teams at Linnaeus.
"Becoming COO is an honour and opportunity that will enable me to help even more people across the business.”
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
In addition, the Association is organising a number of other career events for nurses throughout the year:
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Sponsored by Vets4Pets, Sarah will look at ways the veterinary profession can improve the detection of this condition and enable you to offer practical advice and support for older animals and their owners.
Sarah is an RCVS and European Veterinary Specialist in Behavioural Medicine and was made a Fellow of the Royal College of Veterinary Surgeons in 2018.
She is a Certified Clinical Animal Behaviourist under the ASAB accreditation scheme and registered as a Veterinary Behaviourist with the Animal Behaviour and Training Council.
Dr Huw Stacey, Director of Clinical Services at Vets4Pets (pictured right) said: “Sadly, cognitive dysfunction is a progressive degenerative disease that can affect many of our beloved pets during their lifespan.
"However, various studies have shown that early intervention, using a combination of environmental, nutritional and medicinal approaches, can lead to significant improvement in quality of life.
“As part of our commitment to the wellbeing of pets, we are partnering with Sarah to sponsor this webinar and enable the entire industry to access the latest insights into early detection and proper management of the condition.
“Our aim is to help educate vets and nurses across the nation and empower them in their decision making when diagnosing elderly pets.”
The webinar will consist of a 45-minute webinar and 15-minute Q&A session.
It will count as one hour of CPD, and a recording will be available to attendees for a year following the event.
The webinar also forms part of a wider campaign which will see pet owners polled to ascertain their current understanding of the condition, and ultimately help to raise consumer awareness of cognitive dysfunction.
To register for a free place, visit: https://bit.ly/3IkuC9e
The webinar, which takes place on Thursday 30th June at 7.30pm, is being presented by Debbie Boone, billed as one of America’s most prominent and experienced veterinary communications consultants.
Gerrard Harkins, Premier Vet Alliance’s Commercial Director said: “Many people struggle with managing challenging behaviour and confrontation in the workplace and Debbie will be focusing on providing delegates with pragmatic advice and skills to put into practice.
"She is one of the veterinary industry’s most prominent and successful communicators so we’re extremely fortunate to be able to access her advice.
“We’re also looking forward to gaining a US perspective on this important subject.”
To register for the webinar, visit: https://tinyl.io/5aIk
Mike, an RCVS Queen’s Medal winner, will be in conversation with Catheryn Partington BVSc CertAVP(VC) MSc MRCVS, Jose Matos DVM DipECVIM (Cardiology) MRCVS European and RCVS Recognised Specialist in Small Animal Cardiology (canine and feline cardiology) and Paul Freeman MA, VetMB, Cert SAO, Dip ECVN, MRCVS (European and RCVS Specialist in Veterinary Neurology) (canine and feline neurology).
During the event, they will be explaining how Improve's new Academy Series can help vet professionals meet their annual CPD targets, learn through self-assessment and reflective study, and bring them to the forefront of medicine in several specialist areas.
Heber Alves, CEO of Improve International, said: “Here at Improve International, we are proud to be providing CPD training alongside the historic and prestigious University of Cambridge for our first Academy Series.
"We are excited to be working with many of its pioneering specialists at the Department of Veterinary Medicine and, as a former vet myself, I look forward to hearing how my fellow veterinarians handled the most difficult challenges of their careers.”
www.improveinternational.com
In the study1, which was funded by Universities Federation for Animal Welfare (UFAW), an online questionnaire was completed by 744 snake owners worldwide but predominantly from the UK (68.8%).
The questionnaire investigated housing and husbandry practices and snake health and welfare as measured by clinical signs and behavioural indicators.
Associations between clinical signs, behavioural indicators and housing and husbandry aspects were tested for the three most common snake families: Pythonoids, Boids and Colubrids.
The study found 54.7% of snakes were kept in enclosures shorter in length or height than their body, preventing them from stretching out fully.
10.2% of snakes in the UK were kept in enclosures that do not comply with current recommended guidelines (minimum enclosure length <0.66 of snake length).
Whilst most snake owners (93.1%) reported measuring the temperature in their snakes’ enclosures, 24% of these checked less than the recommended once daily.
When looking at the most commonly owned snake species (royal pythons, corn snakes and common boa constrictors), 47.2% were kept in sub-optimal temperatures for their species.
Furthermore, 48.1% of owners reported not measuring the humidity in their snakes’ enclosure.
Owners reported that many snakes experienced at least one of the listed clinical signs, with the most common issues being skin shedding (28.2%), parasites (11.2%), rostral cuts and scrapes (7.4%) and respiratory problems (5.6%).
Snakes that were kept in enclosures <1 snake length had significantly more clinical signs compared to those snakes kept in enclosures >1 snake length.
Similarly, most snakes were reported to experience at least one of the listed negative behaviours, most commonly interacting with transparent boundaries (52.8%), wincing or withdrawal of head when gently touched (52.4%), putting the head under the substrate (52.1%), unusually high level of activity (51.1%) and attempting to escape (45.9%).
All these negative behaviours have previously been described as associated with captive stress.
Snakes that were reported as having more clinical signs tended to show more reported negative behaviours.
Dr Nicola Rooney, Senior Lecturer in Wildlife and Conservation at Bristol Veterinary School and corresponding author for the paper, said: “Our study has highlighted various concerns for snake welfare.
"The first of these relates to enclosure size, with snakes commonly being kept in vivaria preventing straight-line postures and movement.
"Snakes that were unable to stretch out fully had more clinical signs than those that were able to stretch out fully.
“Whilst we did not find a significant association between temperature or humidity and measures of health and welfare in this study, it is a concern that many snakes were housed in conditions considered sub-optimal for their species.
"We know that appropriate temperature and humidity is vital for maintaining the health of snakes and it would therefore be prudent to investigate these associations further, using methods other than owner reporting.”
Dr Huw Golledge, Animal Welfare Editor-in-Chief, said: “Until now, there has been little empirical data on the housing and husbandry practices of privately kept snakes, and how these impact on their welfare.
"As the first study of this size, this research provides valuable baseline data against which future surveys or welfare interventions can be compared.
“As this survey relies on owner-reported information, it is very likely that many of the frequencies of clinical and behavioural signs are underestimated.
"This demonstrates the need for evidence-based recommendations, and the importance of such recommendations being made accessible to owners to improve snake welfare.”
Photo: Brown and Black Snake in Close Up Photography © deedee Pexels
The research is being conducted by Sarah Mansell under the supervision of Dr. Malgorzata Behnke. They say this parasite hasn't been studied in depth in the UK since the 1970's, because the symptoms can be controlled by routine worming measures. However, as the industry moves away from routine worming as a measure of reducing the risk of parasites developing resistances to treatments, a condition such as this which is now considered to be quite rare in the UK can start to re-emerge.
Sarah is asking vets to fill out a short questionnaire to assess awareness of Onchocerca Cervicalis in veterinary practices. The survey includes specific questions about the parasite as well as questions about cases of unresponsive skin conditions because a similarity in symptoms can lead to misdiagnoses that could, in fact, turn out to be Onchocerca Cervicalis.
Sarah said: "Hopefully the findings will raise awareness of this problem and help shape future research in this area."
She added: "I want to get vets thinking about this issue much more than perhaps they are at the moment."
To take part in the survey, visit: https://harper-adams.onlinesurveys.ac.uk/assessing-the-awareness-of-onchocerca-cervicalis-amongst-e-2
Thiamacare contains 10 mg/ml thiamazole, which is double the concentration of Thyronorm, for a lower dose volume.
Animalcare highlights research which shows that 87.4% of owners prefer liquid medications for their cat1, and that cats find liquid presentations more palatable2.
James Beaumont from Animalcare said: "With the lowest dose volume available, we believe Thiamacare will make the medical management of this condition easier through improved cat acceptance and better owner compliance."
Thiamacare's dosing syringe is marked with a single scale in 1.25 mg increments to facilitate precise dosing in response to total T4 measurement values. The scale does not need converting when switching from other brands or formulations.
Animalcare has developed a range of supporting materials to encourage the use of Thiamacare as the preferred choice for feline hyperthyroid medical management. They include social posts and a post-prescription leaflet to help veterinary teams support owners, particularly through the stabilisation phase post-diagnosis.
A short webinar offering top tips for treating feline hyperthyroidism from feline Specialist Dr Caney will also be available later in October. These resources will all be available at www.the-pac.co.uk.
Ophtocycline is licensed for the treatment of keratitis, conjunctivitis and blepharitis caused by Staphylococcus spp., Streptococcus spp., Proteus spp., and/or Pseudomonas spp.
Dechra says chlortetracycline hydrochloride works against both aerobic and anaerobic Gram-negative and Gram-positive bacteria.
The recommended dosage is four times a day for five days. The 10 mg/g ophthalmic ointment has a 14-day broached shelf life. There is a one-day withdrawal period for meat and offal.
Dechra Brand Manager Carol Morgan said: "Ophtocycline provides veterinary professionals with a targeted treatment to effectively tackle the growing and reproducing bacteria that causes these eye conditions.
"Chlortetracycline is a bacteriostatic antibiotic which interferes with bacterial protein synthesis in the rapidly growing and reproducing bacterial cell and has both time-dependent and concentration dependent effects.
"We are very pleased to be able to roll out this product to the UK market as part of our ophthalmic range alongside popular products such as Isathal."
For more information visit: www.dechra.co.uk
People are invited to organise or join a walk to raise money for Canine Arthritis Management and its work to educate both dog owners and veterinary professionals about how even the smallest of changes can help to enhance the life of a dog with arthritis.
CAM highlights recent work from the Royal Veterinary College and University of Sydney through VetCompass, which highlighted some of the biggest welfare challenges facing our pet population including obesity, dental disease and osteoarthritis, with osteoarthritis identified as one of the most severe conditions.
Hannah said: "We need to start more conversations about arthritis; both dog owners and vets need to be more aware of the steps we can take to help prevent arthritis, and where dogs are affected, how we can take positive action to help them live fulfilled and comfortable lives."
Hannah says that arthritis is currently one of the biggest causes of owners choosing to euthanise their dogs, and she hopes that owners taking part in the walks will help spread the word that arthritis can be managed.
To find out more about the Big September Walks visit www.facebook.com/CAMBigSeptemberWalks